Exact Sciences Corporation (EXAS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Zanotti Katherine S 75,966 株保有. その他の主要保有者には Paulsen Gisela および Doyle James Edward.
過去12ヶ月間にインサイダーは 43 件の取引を実施 EXAS 株式 — 19 件の買い (評価額 $13.89K) および 1 件の売り (評価額 $170.61K). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
EXAS インサイダー保有状況
最大保有者
Zanotti Katherine S
75,966 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Zanotti Katherine S |
Director |
75,966 |
2025-06-16 |
|
| 2 |
Paulsen Gisela |
Gen Mgr, Precision Oncology |
66,267 |
2020-04-22 |
|
| 3 |
Doyle James Edward |
Director |
61,447 |
2025-06-16 |
|
| 4 |
Coward D Scott |
Director |
57,562 |
2025-06-16 |
|
| 5 |
Cunningham Everett |
Chief Commercial Officer |
46,470 |
2024-05-02 |
|
| 6 |
Orville Jacob A |
EVP, GM, Screening |
38,707 |
2026-02-27 |
|
| 7 |
Lidgard Graham Peter |
Chief Science Officer |
34,891 |
2021-03-10 |
|
| 8 |
Levangie Daniel J |
Director |
34,312 |
2025-06-16 |
|
| 9 |
Sebelius Kathleen |
Director |
32,671 |
2024-12-20 |
|
| 10 |
Baranick Brian |
EVP, GM, Precision Oncology |
28,063 |
2026-02-27 |
|
| 11 |
Bloomer Aaron |
EVP, Chief Financial Officer |
28,063 |
2026-02-27 |
|
| 12 |
Clancy Paul J |
Director |
26,038 |
2025-06-16 |
|
| 13 |
Stenhouse Mark |
President, Cologuard |
25,000 |
2020-04-06 |
|
| 14 |
Jacquet Pierre |
Director |
23,576 |
2023-06-12 |
|
| 15 |
Condella Sarah |
EVP, Human Resources |
23,224 |
2026-02-27 |
|
| 16 |
Petrovic Shacey |
Director |
21,804 |
2025-06-16 |
|
| 17 |
Herriott James |
SVP, General Counsel & Sec |
20,321 |
2026-02-27 |
|
| 18 |
Lewis-hall Freda C |
Director |
19,688 |
2023-06-12 |
|
| 19 |
Conroy Kevin T |
President and CEO |
18,143 |
2026-03-03 |
|
| 20 |
Trigg Leslie |
Director |
17,169 |
2025-06-16 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-23 |
Bloomer Aaron |
EVP, Chief Financial Officer |
株式返還 |
28,063 |
- |
- |
| 2026-03-23 |
Herriott James |
SVP, General Counsel & Sec |
株式返還 |
20,321 |
- |
- |
| 2026-03-23 |
Baranick Brian |
EVP, GM, Precision Oncology |
株式返還 |
28,063 |
- |
- |
| 2026-03-23 |
Barber Michael J |
Director |
株式返還 |
7,422 |
- |
- |
| 2026-03-23 |
Condella Sarah |
EVP, Human Resources |
株式返還 |
23,224 |
- |
- |
| 2026-03-23 |
Petrovic Shacey |
Director |
株式返還 |
7,095 |
$0.01 |
$70.95 |
| 2026-03-23 |
Doyle James Edward |
Director |
株式返還 |
5,398 |
- |
- |
| 2026-03-23 |
Clancy Paul J |
Director |
株式返還 |
5,398 |
- |
- |
| 2026-03-23 |
Zanotti Katherine S |
Director |
株式返還 |
5,398 |
- |
- |
| 2026-03-23 |
Popovits Kimberly J |
Director |
株式返還 |
9,656 |
- |
- |
| 2026-03-23 |
Conroy Kevin T |
President and CEO |
株式返還 |
154,829 |
- |
- |
| 2026-03-23 |
Trigg Leslie |
Director |
株式返還 |
13,925 |
- |
- |
| 2026-03-23 |
Orville Jacob A |
EVP, GM, Screening |
株式返還 |
38,707 |
- |
- |
| 2026-03-23 |
Coward D Scott |
Director |
株式返還 |
12,875 |
$98.18 |
$1.26M |
| 2026-02-27 |
Condella Sarah |
EVP, Human Resources |
オプション行使（売却） |
3,900 |
$5.03 |
$19.62K |
| 2026-02-27 |
Conroy Kevin T |
President and CEO |
オプション行使（売却） |
18,143 |
- |
- |
| 2026-02-25 |
Bloomer Aaron |
EVP, Chief Financial Officer |
RSU 付与（制限付株式） |
28,063 |
- |
- |
| 2026-02-25 |
Herriott James |
SVP, General Counsel & Sec |
RSU 付与（制限付株式） |
20,321 |
- |
- |
| 2026-02-25 |
Baranick Brian |
EVP, GM, Precision Oncology |
RSU 付与（制限付株式） |
28,063 |
- |
- |
| 2026-02-25 |
Condella Sarah |
EVP, Human Resources |
RSU 付与（制限付株式） |
23,224 |
- |
- |
| 2026-02-25 |
Conroy Kevin T |
President and CEO |
RSU 付与（制限付株式） |
154,829 |
- |
- |
| 2026-02-25 |
Orville Jacob A |
EVP, GM, Screening |
RSU 付与（制限付株式） |
38,707 |
- |
- |
| 2025-12-24 |
Baranick Brian |
EVP, GM, Precision Oncology |
RSU 源泉徴収 |
14,938 |
$101.59 |
$1.52M |
| 2025-12-23 |
Baranick Brian |
EVP, GM, Precision Oncology |
オプション行使 |
9,450 |
- |
- |
| 2025-12-23 |
Orville Jacob A |
EVP, GM, Screening |
オプション行使（売却） |
16,051 |
- |
- |
